Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent-Reference-Cited by-同舟云学术

Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent

Published:2016-04 Issue:2 Volume:68 Page:250-258
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Kumari Shikha,Mishra Chandra Bhushan,Tiwari Manisha

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference46 articles.

1. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE);Fisher;Epilepsia,2005

2. Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions;Reddy;Int J Mol Sci,2013

3. http://www.who.int/mediacentre/factsheets/fs999/en/.

4. Key factors in the discovery and development of new antiepileptic drugs;Bialer;Nat Rev Drug Discovery,2010

5. Approaches to refractory epilepsy;Engel;Ann Indian Acad Neurol,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropharmacological Potential of Different Piperazine Analogs: A Recent Prospective;Mini-Reviews in Organic Chemistry;2024-01-16

2. Recent Advances in Synthesis and Biological Applications of Substituted Ureas;Current Organic Chemistry;2021-10-14

3. Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure‐Activity Relationships;ChemMedChem;2021-04-07

4. Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors;European Journal of Medicinal Chemistry;2020-04

5. Development of novel N-(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer's disease;RSC Advances;2020